The evolving role of C-reactive protein in atherothrombosis

Sridevi Devaraj, Uma Singh, Ishwarlal Jialal

Research output: Contribution to journalArticle

139 Citations (Scopus)

Abstract

Background: Inflammation is pivotal in all phases of atherosclerosis. Among the numerous inflammatory biomarkers, the largest amount of published data supports a role for C-reactive protein (CRP) as a robust and independent risk marker in the prediction of primary and secondary adverse cardiovascular events. In addition to being a risk marker, there is much evidence indicating that CRP may indeed participate in athero-genesis. content: In this review, we focus on the role of CRP in promoting atherothrombosis by discussing its effects on endothelial cells, endothelial progenitor cells, monocyte-macrophages, and smooth muscle cells. conclusions: CRP is clearly a risk marker for cardiovascular disease and is recommended for use in primary prevention. In addition, CRP appears also to contribute to atherogenesis. However, much further research is needed, especially in appropriate animal models, to confirm the possible role of CRP in promoting atherothrombosis.

Original languageEnglish (US)
Pages (from-to)229-238
Number of pages10
JournalClinical Chemistry
Volume55
Issue number2
DOIs
StatePublished - Feb 1 2009

Fingerprint

C-Reactive Protein
Endothelial cells
Atherosclerosis
Macrophages
Biomarkers
Primary Prevention
Smooth Muscle Myocytes
Muscle
Monocytes
Animals
Cardiovascular Diseases
Endothelial Cells
Animal Models
Cells
Inflammation
Research

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

The evolving role of C-reactive protein in atherothrombosis. / Devaraj, Sridevi; Singh, Uma; Jialal, Ishwarlal.

In: Clinical Chemistry, Vol. 55, No. 2, 01.02.2009, p. 229-238.

Research output: Contribution to journalArticle

Devaraj, Sridevi ; Singh, Uma ; Jialal, Ishwarlal. / The evolving role of C-reactive protein in atherothrombosis. In: Clinical Chemistry. 2009 ; Vol. 55, No. 2. pp. 229-238.
@article{491c39ec13bb4156835fb254aa0787f0,
title = "The evolving role of C-reactive protein in atherothrombosis",
abstract = "Background: Inflammation is pivotal in all phases of atherosclerosis. Among the numerous inflammatory biomarkers, the largest amount of published data supports a role for C-reactive protein (CRP) as a robust and independent risk marker in the prediction of primary and secondary adverse cardiovascular events. In addition to being a risk marker, there is much evidence indicating that CRP may indeed participate in athero-genesis. content: In this review, we focus on the role of CRP in promoting atherothrombosis by discussing its effects on endothelial cells, endothelial progenitor cells, monocyte-macrophages, and smooth muscle cells. conclusions: CRP is clearly a risk marker for cardiovascular disease and is recommended for use in primary prevention. In addition, CRP appears also to contribute to atherogenesis. However, much further research is needed, especially in appropriate animal models, to confirm the possible role of CRP in promoting atherothrombosis.",
author = "Sridevi Devaraj and Uma Singh and Ishwarlal Jialal",
year = "2009",
month = "2",
day = "1",
doi = "10.1373/clinchem.2008.108886",
language = "English (US)",
volume = "55",
pages = "229--238",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "2",

}

TY - JOUR

T1 - The evolving role of C-reactive protein in atherothrombosis

AU - Devaraj, Sridevi

AU - Singh, Uma

AU - Jialal, Ishwarlal

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Background: Inflammation is pivotal in all phases of atherosclerosis. Among the numerous inflammatory biomarkers, the largest amount of published data supports a role for C-reactive protein (CRP) as a robust and independent risk marker in the prediction of primary and secondary adverse cardiovascular events. In addition to being a risk marker, there is much evidence indicating that CRP may indeed participate in athero-genesis. content: In this review, we focus on the role of CRP in promoting atherothrombosis by discussing its effects on endothelial cells, endothelial progenitor cells, monocyte-macrophages, and smooth muscle cells. conclusions: CRP is clearly a risk marker for cardiovascular disease and is recommended for use in primary prevention. In addition, CRP appears also to contribute to atherogenesis. However, much further research is needed, especially in appropriate animal models, to confirm the possible role of CRP in promoting atherothrombosis.

AB - Background: Inflammation is pivotal in all phases of atherosclerosis. Among the numerous inflammatory biomarkers, the largest amount of published data supports a role for C-reactive protein (CRP) as a robust and independent risk marker in the prediction of primary and secondary adverse cardiovascular events. In addition to being a risk marker, there is much evidence indicating that CRP may indeed participate in athero-genesis. content: In this review, we focus on the role of CRP in promoting atherothrombosis by discussing its effects on endothelial cells, endothelial progenitor cells, monocyte-macrophages, and smooth muscle cells. conclusions: CRP is clearly a risk marker for cardiovascular disease and is recommended for use in primary prevention. In addition, CRP appears also to contribute to atherogenesis. However, much further research is needed, especially in appropriate animal models, to confirm the possible role of CRP in promoting atherothrombosis.

UR - http://www.scopus.com/inward/record.url?scp=59649104145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59649104145&partnerID=8YFLogxK

U2 - 10.1373/clinchem.2008.108886

DO - 10.1373/clinchem.2008.108886

M3 - Article

C2 - 19095731

AN - SCOPUS:59649104145

VL - 55

SP - 229

EP - 238

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 2

ER -